283 related articles for article (PubMed ID: 7629507)
1. Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors.
Suzuki T; Tahara H; Narula S; Moore KW; Robbins PD; Lotze MT
J Exp Med; 1995 Aug; 182(2):477-86. PubMed ID: 7629507
[TBL] [Abstract][Full Text] [Related]
2. Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice.
Berman RM; Suzuki T; Tahara H; Robbins PD; Narula SK; Lotze MT
J Immunol; 1996 Jul; 157(1):231-8. PubMed ID: 8683120
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of myeloid dendritic cells retrovirally transduced to express mammalian or viral interleukin-10 on cytotoxic T lymphocyte and natural killer cell functions and resistance to tumor growth.
Takayama T; Tahara H; Thomson AW
Transplantation; 2001 May; 71(9):1334-40. PubMed ID: 11397973
[TBL] [Abstract][Full Text] [Related]
4. Paralysis of B7 co-stimulation through the effect of viral IL-10 on T cells as a mechanism of local tolerance induction.
Müller A; Schmitt L; Raftery M; Schönrich G
Eur J Immunol; 1998 Nov; 28(11):3488-98. PubMed ID: 9842891
[TBL] [Abstract][Full Text] [Related]
5. Viral interleukin-10-engineered autologous hematopoietic stem cell therapy: a novel gene therapy approach to prevent graft rejection.
Salgar SK; Yang D; Ruiz P; Miller J; Tzakis AG
Hum Gene Ther; 2004 Feb; 15(2):131-44. PubMed ID: 14975186
[TBL] [Abstract][Full Text] [Related]
6. Partial purification of murine tumor-associated peptide epitopes common to histologically distinct tumors, melanoma and sarcoma, that are presented by H-2Kb molecules and recognized by CD8+ tumor-infiltrating lymphocytes.
Itoh T; Storkus WJ; Gorelik E; Lotze MT
J Immunol; 1994 Aug; 153(3):1202-15. PubMed ID: 7517974
[TBL] [Abstract][Full Text] [Related]
7. Viral IL-10-induced immunosuppression requires Th2 cytokines and impairs APC function within the allograft.
Qin L; Ding Y; Tahara H; Bromberg JS
J Immunol; 2001 Feb; 166(4):2385-93. PubMed ID: 11160297
[TBL] [Abstract][Full Text] [Related]
8. T cell stimulation upon long-term secretion of viral IL-10.
Müller A; Raftery M; Schönrich G
Eur J Immunol; 1999 Sep; 29(9):2740-7. PubMed ID: 10508248
[TBL] [Abstract][Full Text] [Related]
9. Transduction of dendritic cell progenitors with a retroviral vector encoding viral interleukin-10 and enhanced green fluorescent protein allows purification of potentially tolerogenic antigen-presenting cells.
Takayama T; Tahara H; Thomson AW
Transplantation; 1999 Dec; 68(12):1903-9. PubMed ID: 10628772
[TBL] [Abstract][Full Text] [Related]
10. Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness.
Takayama T; Nishioka Y; Lu L; Lotze MT; Tahara H; Thomson AW
Transplantation; 1998 Dec; 66(12):1567-74. PubMed ID: 9884241
[TBL] [Abstract][Full Text] [Related]
11. [Transfection with virus interleukin-10 to prolong murine heart allograft].
Yang DH; Wu MC; Peng MH; Tzakis A
Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(2):87-91. PubMed ID: 15771810
[TBL] [Abstract][Full Text] [Related]
12. The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor.
Liu Y; de Waal Malefyt R; Briere F; Parham C; Bridon JM; Banchereau J; Moore KW; Xu J
J Immunol; 1997 Jan; 158(2):604-13. PubMed ID: 8992974
[TBL] [Abstract][Full Text] [Related]
13. Lipid-mediated gene transfer of viral IL-10 prolongs vascularized cardiac allograft survival by inhibiting donor-specific cellular and humoral immune responses.
DeBruyne LA; Li K; Chan SY; Qin L; Bishop DK; Bromberg JS
Gene Ther; 1998 Aug; 5(8):1079-87. PubMed ID: 10326031
[TBL] [Abstract][Full Text] [Related]
14. Viral IL-10 gene transfer prolongs rat islet allograft survival.
Kim YH; Lim DG; Wee YM; Kim JH; Yun CO; Choi MY; Park YH; Kim SC; Han DJ
Cell Transplant; 2008; 17(6):609-18. PubMed ID: 18819249
[TBL] [Abstract][Full Text] [Related]
15. Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.
Aoki T; Tashiro K; Miyatake S; Kinashi T; Nakano T; Oda Y; Kikuchi H; Honjo T
Proc Natl Acad Sci U S A; 1992 May; 89(9):3850-4. PubMed ID: 1570303
[TBL] [Abstract][Full Text] [Related]
16. Suppression of allogeneic response by viral IL-10 gene transfer.
Fujisawa K; Saito S; Okada Y; Fujiwara T; Yagi T; Iwagaki H; Tanaka N
Cell Transplant; 2003; 12(4):379-87. PubMed ID: 12911125
[TBL] [Abstract][Full Text] [Related]
17. Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6.
Hideshima T; Chauhan D; Teoh G; Raje N; Treon SP; Tai YT; Shima Y; Anderson KC
Clin Cancer Res; 2000 Mar; 6(3):1180-9. PubMed ID: 10741750
[TBL] [Abstract][Full Text] [Related]
18. Suppression of autoimmune diabetes by viral IL-10 gene transfer.
Yang Z; Chen M; Wu R; Fialkow LB; Bromberg JS; McDuffie M; Naji A; Nadler JL
J Immunol; 2002 Jun; 168(12):6479-85. PubMed ID: 12055268
[TBL] [Abstract][Full Text] [Related]
19. Suppression of T(h)1 cell activation and prevention of autoimmune diabetes in NOD mice by local expression of viral IL-10.
Kawamoto S; Nitta Y; Tashiro F; Nakano A; Yamato E; Tahara H; Tabayashi K; Miyazaki J
Int Immunol; 2001 May; 13(5):685-94. PubMed ID: 11312256
[TBL] [Abstract][Full Text] [Related]
20. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector.
Tahara H; Zitvogel L; Storkus WJ; Zeh HJ; McKinney TG; Schreiber RD; Gubler U; Robbins PD; Lotze MT
J Immunol; 1995 Jun; 154(12):6466-74. PubMed ID: 7759882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
